Healthcare company, Procter & Gamble, has confirmed that it is expecting to see earning per share for the January to March quarter of between $0.60 and $0.62.
In a statement, the company also confirmed that it is expecting total sales growth for the three-month period to be in the high single-digit range.
For the full-year, which ends in June 2005, P&G previously said it hoped to reach the upper-half of analysts’ estimates, or between $2.59 and $2.61 per share – up 12% on 2004 [[09/12/04g]], [[03/08/04b]]. Operating profit margins are forecast to improve “modestly” in spite of rising costs.
